Digma Medical

Corporate Website: https://www.digmamedical.com/

Digma is developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels.

Digma aims to harness the power of the small intestine to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that dramatically improve their quality of life and long-term health outcomes.